|
⚲
|
| Keyboard |
| UroGen Pharma Ltd | |
|---|---|
| Ticker | URGN |
| CIK # | 0001668243 |
| CUSIP | M96088105 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 9 Ha'Ta'Asiya St, Ra'Anana, 4365007 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| UroGen Pharma Ltd | 2023-08-14 | 120.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $3,240,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001668243] | 10-K | |
| [0001668243] | 10-Q | |
| [0001668243] | 3 | |
| [0001668243] | 4 | |
| [0001668243] | 6-K | |
| [0001668243] | 8-K | |
| [0001668243] | D | |
| [0001668243] | SC 13D | |
| [0001668243] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Smith Jason Drew
Ordinary Shares
|
2026-02-03 | Sell | 1,608 | $19.69 | 31,662 |
|
Schoenberg Mark
Ordinary Shares
|
2026-02-03 | Sell | 3,686 | $19.69 | 72,577 |
|
Schoenberg Mark
Ordinary Shares
|
2026-02-03 | Sell | 1,843 | $19.69 | 36,289 |
|
Smith Jason Drew
Ordinary Shares
|
2026-02-03 | Sell | 2,654 | $19.69 | 52,257 |
|
Schoenberg Mark
Ordinary Shares
|
2026-02-03 | Sell | 1,844 | $19.69 | 36,308 |
|
Smith Jason Drew
Ordinary Shares
|
2026-02-03 | Sell | 3,217 | $19.69 | 63,343 |
|
Schoenberg Mark
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 3,334 | $0.00 | |
|
Smith Jason Drew
Ordinary Shares
|
2026-01-31 | Option exercise | 5,500 | ||
|
Schoenberg Mark
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 20,000 | $0.00 | |
|
Barrett Elizabeth A
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 153,195 | $0.00 | |
|
Smith Jason Drew
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 6,667 | $0.00 | |
|
Degnan Chris
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 32,609 | $0.00 | |
|
Schoenberg Mark
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 3,333 | $0.00 | |
|
Smith Jason Drew
Ordinary Shares
|
2026-01-31 | Option exercise | 3,333 | ||
|
Schoenberg Mark
Ordinary Shares
|
2026-01-31 | Option exercise | 3,333 | ||
|
Schoenberg Mark
Ordinary Shares
|
2026-01-31 | Option exercise | 6,666 | ||
|
Smith Jason Drew
Ordinary Shares
|
2026-01-31 | Option exercise | 6,667 | ||
|
Schoenberg Mark
Ordinary Shares
|
2026-01-31 | Option exercise | 3,334 | ||
|
Smith Jason Drew
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 3,333 | $0.00 | |
|
Smith Jason Drew
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 32,609 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 174 | 45,055,623 |
| 2025-12-31 | 170 | 42,294,814 |
| 2025-09-30 | 163 | 43,995,785 |
| 2025-06-30 | 153 | 40,209,705 |
| 2025-03-31 | 141 | 40,546,991 |
| 2024-12-31 | 139 | 35,118,373 |
| 2024-09-30 | 129 | 34,068,569 |
| 2024-06-30 | 117 | 37,327,674 |
| 2024-03-31 | 113 | 26,611,534 |
| 2023-12-31 | 107 | 20,325,989 |
| 2023-09-30 | 103 | 16,195,244 |
| 2023-06-30 | 87 | 11,516,035 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Hennion & Walsh Asset Management Inc | [2026-06-30] | SOLE | 276,696 | 276,696 |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 199 | 7,642 |
| Brookstone Capital Management | [2026-06-30] | SOLE | 0 | 6,000 |
| Activest Wealth Management | [2026-06-30] | SOLE | 0 | 1,001 |
| Gamma Investing LLC | [2026-06-30] | DFND | 441 | 441 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 31 | 31 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 24 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 16 |
| Hughes Financial Services LLC | [2026-06-30] | SOLE | 3 | 3 | Prev | Page 1 | Next |